NEPH 1.5 (-5.66%)
US6406714005• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. NEPH

Nephros (NEPH) Competitor Comparison

We are evaluating the key criteria listed to compare Nephros (NEPH) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

38 / 44

Gross Profits

37 / 40

Total Revenue

37 / 43

EBITDA

28 / 44

Free Cashflow

27 / 44

Quick Ratio

13 / 44

Earnings per Share

21 / 44

Dividend yield

0 / 13

Total Cash

41 / 44

Performance 3 years

38 / 44

Performance 5 years

38 / 44

Performance 10 years

37 / 44

Linearity 3 years

39 / 44

Linearity 5 years

34 / 44

Linearity 10 years

17 / 44

Total Rank

17 / 44

Dividend Rank

28 / 44

Valuation Rank

27 / 44

Piotroski Rank

29 / 44

Muliplier Rank

16 / 44

Linearity 3 years - NEPH ranking 39 / 44

These are the competitors of Nephros in the industry Medical Instruments & Supplies ranked by linearity 3 years
1. Cooper Companies COO
112.23
2. Bausch & Lomb BLCO
78.98
3. NexGel NXGL
67.03
4. Alcon ALC
57.02
5. Hologic HOLX
45.3
6. Steris STE
33.19
7. Becton, Dickinson BDX
22.23
8. Ansell PD1.F
21.5
9. KORU Medical Systems KRMD
18.6
10. ResMed RMD
17.64
11. iRhythm Technologies IRTC
14.07
12. West Pharmaceutical Services WST
6.07
13. Atrion ATRI
5.41
14. ICU Medical ICUI
5.24
15. electroCore ECOR
5
16. Teleflex TFX
4.88
17. Pulse Biosciences PLSE
4.63
18. Utah Medical Products UTMD
4.46
19. Envista Holdings NVST
3.89
20. Merit Medical Systems MMSI
3.57
21. Haemonetics HAE
3.46
22. Repligen RGEN
3.46
23. Baxter BAX
3.15
24. Dentsply Sirona XRAY
3.07
25. Masimo MASI
3.06
26. AtriCure ATRC
3
27. OraSure Technologies OSUR
2.96
28. Harvard Bioscience HBIO
2.61
29. Akoya Biosciences AKYA
2.6
30. Intuitive Surgical ISRG
2.59
31. BioLife Solutions BLFS
2.42
32. Staar Surgical STAA
2.36
33. Microbot Medical MBOT
2.24
34. AngioDynamics ANGO
2.18
35. NovoCure NVCR
2.13
36. Warby Parker WRBY
2.02
37. Ekso Bionics Holdings EKSO
1.98
38. Predictive Oncology POAI
1.92
39. Nephros NEPH
1.79
40. NeuroMetrix NURO
1.54
41. Femasys FEMY
1.52
42. LeMaitre Vascular LMAT
1.38
43. Glaukos GKOS
0.6
44. Pro-Dex PDEX
0.53
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.